SCGB2B2
gene geneOn this page
Also known as SCGB4A2
Summary
SCGB2B2 (secretoglobin family 2B member 2, HGNC:27616) is a protein-coding gene on chromosome 19q13.12, encoding Secretoglobin family 2B member 2 (Q4G0G5).
Predicted to be located in extracellular region.
Source: NCBI Gene 284402 — RefSeq curated summary.
At a glance
- GWAS associations: 1
- Clinical variants (ClinVar): 21 total
- MANE Select transcript:
NM_001025591
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27616 |
| Approved symbol | SCGB2B2 |
| Name | secretoglobin family 2B member 2 |
| Location | 19q13.12 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | SCGB4A2 |
| Ensembl gene | ENSG00000205209 |
| Ensembl biotype | protein_coding |
| OMIM | 615063 |
| Entrez | 284402 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 protein_coding_CDS_not_defined
ENST00000379204, ENST00000595326, ENST00000601241
RefSeq mRNA: 1 — MANE Select: NM_001025591
NM_001025591
CCDS: CCDS32989
Canonical transcript exons
ENST00000601241 — 4 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001480067 | 34594175 | 34594359 |
| ENSE00002984581 | 34675630 | 34677159 |
| ENSE00003154989 | 34594503 | 34596594 |
| ENSE00003918625 | 34590644 | 34593599 |
Expression profiles
Bgee: expression breadth ubiquitous, 157 present calls, max score 78.66.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0366 / max 6.9691, expressed in 15 samples.
FANTOM5 promoters (2 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 180443 | 0.0312 | 14 |
| 180442 | 0.0054 | 2 |
Top tissues by expression
246 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 78.66 | gold quality |
| epithelium of nasopharynx | UBERON:0001951 | 70.22 | gold quality |
| right lobe of liver | UBERON:0001114 | 69.04 | gold quality |
| apex of heart | UBERON:0002098 | 68.76 | gold quality |
| skin of leg | UBERON:0001511 | 67.59 | gold quality |
| body of pancreas | UBERON:0001150 | 66.91 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 66.79 | gold quality |
| right uterine tube | UBERON:0001302 | 66.49 | gold quality |
| germinal epithelium of ovary | UBERON:0001304 | 66.47 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 66.29 | gold quality |
| gastrocnemius | UBERON:0001388 | 66.22 | gold quality |
| muscle of leg | UBERON:0001383 | 66.03 | gold quality |
| gingival epithelium | UBERON:0001949 | 65.88 | gold quality |
| left testis | UBERON:0004533 | 65.62 | gold quality |
| skin of abdomen | UBERON:0001416 | 65.57 | gold quality |
| right testis | UBERON:0004534 | 65.57 | gold quality |
| zone of skin | UBERON:0000014 | 64.85 | gold quality |
| left adrenal gland | UBERON:0001234 | 64.81 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 64.67 | gold quality |
| right adrenal gland | UBERON:0001233 | 64.62 | gold quality |
| left lobe of thyroid gland | UBERON:0001120 | 64.55 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 64.51 | gold quality |
| pancreas | UBERON:0001264 | 63.88 | gold quality |
| testis | UBERON:0000473 | 63.87 | gold quality |
| thyroid gland | UBERON:0002046 | 63.65 | gold quality |
| adrenal cortex | UBERON:0001235 | 62.84 | gold quality |
| adrenal gland | UBERON:0002369 | 62.72 | gold quality |
| adrenal tissue | UBERON:0018303 | 62.71 | gold quality |
| colonic epithelium | UBERON:0000397 | 62.46 | silver quality |
| C1 segment of cervical spinal cord | UBERON:0006469 | 62.00 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6142 | no | 28.13 |
| E-ANND-3 | no | 2.47 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
105 targeting SCGB2B2, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4510 | 100.00 | 66.60 | 2050 |
| HSA-MIR-6127 | 100.00 | 66.76 | 2188 |
| HSA-MIR-6129 | 100.00 | 66.46 | 2080 |
| HSA-MIR-6130 | 100.00 | 66.69 | 2012 |
| HSA-MIR-6133 | 100.00 | 66.48 | 2064 |
| HSA-MIR-6870-5P | 99.99 | 68.55 | 2115 |
| HSA-MIR-4534 | 99.99 | 66.58 | 1907 |
| HSA-MIR-4500 | 99.99 | 72.72 | 2367 |
| HSA-LET-7A-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7B-5P | 99.98 | 72.31 | 1790 |
| HSA-LET-7C-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7E-5P | 99.98 | 72.29 | 1790 |
| HSA-LET-7F-5P | 99.98 | 72.56 | 1784 |
| HSA-LET-7G-5P | 99.98 | 72.37 | 1784 |
| HSA-LET-7I-5P | 99.98 | 72.37 | 1788 |
| HSA-MIR-98-5P | 99.98 | 72.33 | 1787 |
| HSA-MIR-7111-5P | 99.97 | 68.48 | 2062 |
| HSA-MIR-4723-5P | 99.97 | 68.70 | 2034 |
| HSA-MIR-5698 | 99.97 | 68.49 | 2029 |
| HSA-MIR-3658 | 99.96 | 73.87 | 4379 |
| HSA-MIR-4487 | 99.96 | 64.58 | 1252 |
| HSA-MIR-4728-5P | 99.85 | 69.39 | 4718 |
| HSA-MIR-4447 | 99.85 | 67.81 | 2900 |
| HSA-MIR-765 | 99.84 | 68.24 | 2442 |
| HSA-MIR-544A | 99.84 | 68.66 | 1965 |
| HSA-MIR-1321 | 99.84 | 65.30 | 1811 |
| HSA-MIR-6785-5P | 99.82 | 68.68 | 4428 |
| HSA-MIR-11181-3P | 99.75 | 66.38 | 2205 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-149-3P | 99.72 | 68.22 | 3963 |
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Secretoglobin family 2B member 2 — Q4G0G5 (reviewed: Q4G0G5)
Alternative names: Secretoglobin-like protein
All UniProt accessions (1): Q4G0G5
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Secreted.
Similarity. Belongs to the secretoglobin family.
RefSeq proteins (1): NP_001020762* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR016126 | Secretoglobin | Family |
| IPR035960 | Secretoglobin_sf | Homologous_superfamily |
| IPR053723 | Secretoglobin_Domain_sf | Homologous_superfamily |
Pfam: PF01099
UniProt features (2 total): signal peptide 1, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q4G0G5-F1 | 81.71 | 0.16 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 23 (showing top):
PAX3_TARGET_GENES, PAX7_TARGET_GENES, MIR3658, MIR4728_5P, MIR6785_5P, MIR494_3P, MIR4516, MIR4723_5P, MIR6870_5P, MIR7111_5P, MIR5698, MIR5703, MIR4434, MIR20A_3P, MIR889_5P
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (1): extracellular region (GO:0005576)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
150 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| SCGB2B2 | ZNF599 | Q96NL3 | 507 |
| SCGB2B2 | WTIP | A6NIX2 | 507 |
| SCGB2B2 | ZNF181 | Q2M3W8 | 505 |
| SCGB2B2 | ZNF30 | P17039 | 475 |
| SCGB2B2 | UBA2 | Q9UBT2 | 446 |
| SCGB2B2 | E7EVR1 | E7EVR1 | 417 |
| SCGB2B2 | SCGB1D2 | O95969 | 398 |
| SCGB2B2 | PAXBP1 | Q9Y5B6 | 398 |
| SCGB2B2 | SCGB2A1 | O75556 | 371 |
| SCGB2B2 | SCGB2A2 | Q13296 | 348 |
| SCGB2B2 | CYTH4 | Q9UIA0 | 323 |
| SCGB2B2 | RIT2 | Q99578 | 321 |
| SCGB2B2 | KLHL41 | O60662 | 311 |
| SCGB2B2 | ZSCAN30 | Q86W11 | 301 |
| SCGB2B2 | EOLA1 | Q8TE69 | 284 |
IntAct
4 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SCGB2B2 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| SCGB2B2 | UBQLN2 | psi-mi:“MI:0915”(physical association) | 0.000 |
BioGRID (3): SCGB2B2 (Affinity Capture-RNA), SCGB2B2 (Two-hybrid), SCGB2B2 (Positive Genetic)
ESM2 similar proteins: A0A8M9PDM1, A0JNP2, O09051, O75556, O95968, O95969, P02779, P02780, P02781, P02782, P04769, P06913, P09320, P0DMR2, P11684, P17559, P28902, P30438, P30440, P33578, P33579, P33580, P33680, P70664, P70668, P79897, Q02747, Q05702, Q06318, Q0PGP2, Q13296, Q16661, Q28358, Q2VPS3, Q4G0G5, Q6UGQ3, Q6XE38, Q7M742, Q7M747, Q8CGZ9
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
21 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 21 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
1397 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 19:34623269:T:A | donor_gain | 1.0000 |
| 19:34637598:C:CT | acceptor_gain | 1.0000 |
| 19:34637604:C:CT | acceptor_gain | 1.0000 |
| 19:34675625:CTGA:C | donor_loss | 1.0000 |
| 19:34675627:GAC:G | donor_loss | 1.0000 |
| 19:34675628:ACC:A | donor_loss | 1.0000 |
| 19:34593600:C:CC | acceptor_gain | 0.9900 |
| 19:34594173:A:AC | donor_gain | 0.9900 |
| 19:34594174:C:CC | donor_gain | 0.9900 |
| 19:34594356:TCCCC:T | acceptor_loss | 0.9900 |
| 19:34594357:CCC:C | acceptor_gain | 0.9900 |
| 19:34594357:CCCCT:C | acceptor_loss | 0.9900 |
| 19:34594358:CCC:C | acceptor_gain | 0.9900 |
| 19:34594358:CCCTG:C | acceptor_loss | 0.9900 |
| 19:34594360:C:G | acceptor_loss | 0.9900 |
| 19:34594361:T:C | acceptor_loss | 0.9900 |
| 19:34594369:A:C | acceptor_gain | 0.9900 |
| 19:34632641:C:CC | acceptor_gain | 0.9900 |
| 19:34637599:A:T | acceptor_gain | 0.9900 |
| 19:34637605:A:C | acceptor_gain | 0.9900 |
| 19:34675644:CTG:C | donor_gain | 0.9900 |
| 19:34594196:T:C | donor_gain | 0.9800 |
| 19:34594249:C:CA | donor_gain | 0.9800 |
| 19:34594356:TCCC:T | acceptor_gain | 0.9800 |
| 19:34594357:CCCC:C | acceptor_gain | 0.9800 |
| 19:34594358:CC:C | acceptor_gain | 0.9800 |
| 19:34594359:CC:C | acceptor_gain | 0.9800 |
| 19:34594360:C:CC | acceptor_gain | 0.9800 |
| 19:34594369:A:AC | acceptor_gain | 0.9800 |
| 19:34632639:CA:C | acceptor_gain | 0.9800 |
AlphaMissense
626 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 19:34594220:A:C | F67L | 0.939 |
| 19:34594220:A:T | F67L | 0.939 |
| 19:34594222:A:G | F67L | 0.939 |
| 19:34594223:G:C | C66W | 0.935 |
| 19:34594221:A:C | F67C | 0.920 |
| 19:34593573:G:C | C91W | 0.916 |
| 19:34594225:A:G | C66R | 0.911 |
| 19:34594242:A:C | F60C | 0.909 |
| 19:34594224:C:G | C66S | 0.905 |
| 19:34594225:A:T | C66S | 0.905 |
| 19:34594241:G:C | F60L | 0.903 |
| 19:34594241:G:T | F60L | 0.903 |
| 19:34594243:A:G | F60L | 0.903 |
| 19:34594281:A:G | L47P | 0.895 |
| 19:34594513:G:C | S17R | 0.883 |
| 19:34594513:G:T | S17R | 0.883 |
| 19:34594515:T:G | S17R | 0.883 |
| 19:34594221:A:G | F67S | 0.880 |
| 19:34594281:A:T | L47H | 0.879 |
| 19:34594526:G:T | A13D | 0.859 |
| 19:34594518:A:G | C16R | 0.858 |
| 19:34593575:A:G | C91R | 0.857 |
| 19:34594233:A:T | V63D | 0.856 |
| 19:34594229:C:A | Q64H | 0.846 |
| 19:34594229:C:G | Q64H | 0.846 |
| 19:34594224:C:T | C66Y | 0.841 |
| 19:34594242:A:G | F60S | 0.837 |
| 19:34594538:G:T | A9D | 0.823 |
| 19:34593592:A:G | I85T | 0.814 |
| 19:34594224:C:A | C66F | 0.802 |
dbSNP variants (sampled 300 via entrez): RS1000081389 (19:34613281 T>A), RS1000099324 (19:34655141 C>T), RS1000217505 (19:34658877 C>A,T), RS1000219234 (19:34605684 T>C), RS1000288721 (19:34611098 T>C), RS1000293843 (19:34593918 G>C), RS1000297697 (19:34649309 G>A), RS1000344115 (19:34623124 T>C), RS1000377613 (19:34621939 G>T), RS1000392498 (19:34614991 T>C), RS1000438698 (19:34616332 A>G), RS1000442751 (19:34628186 C>T), RS1000496653 (19:34626913 G>A), RS1000501502 (19:34644740 A>G), RS1000546319 (19:34591412 G>C,T)
Disease associations
OMIM: gene MIM:615063 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
1 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST012490_225 | Femur bone mineral density x serum urate levels interaction | 3.000000e-10 |
EFO canonical traits (1, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004531 | urate measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
4 total (human), top 4 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| abrine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Diethylhexyl Phthalate | decreases expression | 1 |
| Nickel | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.